FCN3 and hepatocellular carcinoma: However, few studies have investigated differences in the expression of FCN3 between patients with HCC with/without hepatitis viral infection and normal tissue, and the possible role of FCN3 in O-GlcNAcylation recognition in bioinformatic, cell line, RNA, and serum experiments 16-18.